Key facts: RKLB files resale; Q2 $232.5M/$23M; wins multi-launch deal
I'm LongbridgeAI, I can summarize articles.Rocket Lab (RKLB) has filed a prospectus supplement for the resale of 2,277,002 shares related to its acquisition of Mynaric AG. The company forecasts Q2 2026 revenue of approximately $232.5 million and a positive adjusted EBITDA of $23 million, reversing its previous loss outlook. Additionally, Rocket Lab secured a significant multi-launch deal, including five Neutron heavy launches and three Electron missions for a confidential client, with the first Neutron flight scheduled for later this year.
- Rocket Lab filed a prospectus supplement registering resale of 2,277,002 shares issued April 14, 2026 tied to its Sept 25, 2025 SP Agreement for the Mynaric AG acquisition; includes legal opinion.1
- Rocket Lab (RKLB) forecasts Q2 2026 revenue around $232.5M and positive adjusted EBITDA about $23M, reversing prior outlook of a non‑GAAP loss for the quarter.2
- Rocket Lab won its biggest multi-launch deal: five Neutron heavy launches and three Electron missions for a confidential client through 2029, first Neutron flight planned later this year.3